Clinical trials
6 active studies led by bioLytical Laboratories, of 16 in all
Source: ClinicalTrials.gov, Studies with bioLytical Laboratories (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 11Markets in public records
- 0Regions & countries
- 6Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by bioLytical Laboratories or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on bioLytical Laboratories
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies bioLytical Laboratories leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with bioLytical Laboratories or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show bioLytical Laboratories: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets bioLytical Laboratories is in.
From our blog
Stories on the topics bioLytical Laboratories works in.
Dermatology Diagnostics: AI and Skin Health
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read
Molecular Point-of-Care Tests: Lab Accuracy, Clinic Speed
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
Healthcare In-Vitro Diagnostics: What Comes After COVID
COVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
ReadSearch all reports for bioLytical Laboratories All companies